Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Biovation and Tanox enter agreement for antiinflammatory product development

July 7, 1999

Selective Genetics' GAM technology enhances delivery and retention of NTF gene therapy

July 6, 1999

Cambridge Combinatorial to provide chemistry services to Pfizer

July 5, 1999

Lexicon Genetics reports on new drug discovery technology

July 2, 1999

Targeted Genetics obtains exclusive rights to AAV manufacturing patent

July 2, 1999

Potent murine CCR2 receptor antagonist presented at World Congress on Inflammation

July 1, 1999

Gene sequences related to X-linked inhibitor of apoptosis protein discovered

July 1, 1999

Lundbeck develops radiolabeled 5-HT2 receptor antagonist for PET studies

June 30, 1999

ICAgen licenses novel ion channel genes from SUNY

June 30, 1999

CyDex and Peptichemio sign licensing agreement for drug delivery technology

June 28, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...